The drugbank database (https://www.drugbank.ca) also reports CAD candidate gene LRP1 and its first neighbor CALR as targets for the fibrinolytic agent tenecteplase (recombinant tissue plasminogen activator tPA). The gene discussed is LRP1; the disease is coronary artery disorder.